Learning objectives:
(1) Review the management of endocrine resistant breast cancer in males per NCCN guidelines
(2) Evaluate research studies which analyze the use of endocrine therapy in male breast cancer
(3) Review genetic mutations associated with male breast cancer
 

Session date: 
09/24/2026 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dan Olivieri, MD, MPA